Blog
RSS FeedPosted by Michael Wonder on 05 Aug 2016
PBAC post-market reviews of chronic obstructive pulmonary disease medicines and ezetimibe
5 August 2016 - The public submission process is now closed. ...
Posted by Michael Wonder on 06 Jan 2016
PBAC rebukes Amgen for lodging early submission for Repatha under TGA-PBAC parallel process
6 January 2016 - The PBAC noted that the intent of the submission was to initiate a dialogue rather than ...